Security Snapshot

CalciMedica, Inc. - Common Stock (CALC) Institutional Ownership

CUSIP: 38942Q202

13F Institutional Holders and Ownership History from Q2 2023 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

31

Shares (Excl. Options)

8,322,155

Price

$1.03

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+7,224,332
Value change
+$7,393,034
Number of holders
31
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
35,825,367
SEC-reported price per share
$0.74
Insider filing price
$0.74
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CALC - CalciMedica, Inc. - Common Stock is tracked under CUSIP 38942Q202.
  • 31 institutions reported positions in Q2 2026.
  • 11 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 27 to 31 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $592,510 to $8,389,136.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 31 institutions filings for Q2 2026.

Open SEC evidence

Security key

38942Q202

Latest holder period

Q2 2026

13F holders

31

13D/G owners

11

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
11
Security
CALC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALAFI CAPITAL CO LLC 20% +16% $6,064,885 +$1,660,768 7,220,101 +38% Alafi Capital Company LLC 19 Aug 2026
Avenue Venture Opportunities Fund II, L.P. 5% -43% $2,877,521 +$2,034,598 4,641,163 +241% Avenue Venture Opportunities Fund II, L.P. 23 Jun 2026
Bering Partners II GP, L.L.C. 10% +44% $2,984,854 +$1,209,503 3,553,398 +68% Bering Partners II GP, L.L.C. 19 Aug 2026
ARMISTICE CAPITAL, LLC 10% $2,797,316 3,411,361 Armistice Capital, LLC 30 Jun 2026
Woodline Partners LP 8.1% $2,041,578 2,489,729 Woodline Partners LP 30 Jun 2026
Stonepine Capital Management, LLC 6% +28% $1,805,598 +$1,277,514 2,149,522 +242% Stonepine Capital Management, LLC 19 Aug 2026
Valence Investments SPV VI, LLC 6.4% $1,218,868 1,965,916 Eric W. Roberts 25 Jun 2026
CVI Investments, Inc. 5.1% $1,602,763 1,556,081 CVI Investments, Inc. 23 Jun 2026
Aisling Capital V, LP 3.9% $1,180,323 781,671 Aisling Capital V, LP 03 Mar 2025
Flynn James E 4.3% $4,304,937 653,253 Deerfield Mgmt, L.P. 06 Feb 2026
Soleus Private Equity Fund III, L.P. 2.4% -64% $246,930 -$430,860 391,952 -64% Soleus Capital Management, L.P. 31 Mar 2026

As of 30 Jun 2026, 31 institutional investors reported holding 8,322,155 shares of CalciMedica, Inc. - Common Stock (CALC). This represents 23% of the company’s total 35,825,367 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
23%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Woodline Partners LP 6.9% 2,489,729 0.01% $2,564,421
HEIGHTS CAPITAL MANAGEMENT, INC 4.3% 1,556,081 0.37% $1,602,763
STEMPOINT CAPITAL LP 3.5% 1,244,864 0.21% $1,195,661
Squadron Capital Management LLC 3.5% 1,244,864 0.44% $1,282,210
Stonepine Capital Management, LLC 1.7% 622,432 0.42% $544,939
L1 Global Manager Pty Ltd 0.69% 248,972 0.21% $256,441
MORGAN STANLEY 0.4% 143,245 0% $147,543
GEODE CAPITAL MANAGEMENT, LLC 0.31% 110,477 -10% 0% $113,846
RENAISSANCE TECHNOLOGIES LLC 0.27% 97,300 -24% 0% $100,219
VANGUARD CAPITAL MANAGEMENT LLC 0.25% 88,956 -47% 0% $91,625
180 WEALTH ADVISORS, LLC 0.23% 83,400 -34% 0.01% $85,902
XTX Topco Ltd 0.22% 78,288 0% $80,637
Cambridge Investment Research Advisors, Inc. 0.17% 60,000 0% 0% $62,000
HRT FINANCIAL LP 0.13% 46,825 +18% 0% $48,000
VANGUARD FIDUCIARY TRUST CO 0.13% 45,829 0% 0% $47,204
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.12% 43,968 +43% 0% $45,287
Rockefeller Capital Management L.P. 0.06% 20,000 +300% 0% $20,600
GSA CAPITAL PARTNERS LLP 0.05% 17,469 -27% 0% $18,000
STATE STREET CORP 0.05% 17,073 0% 0% $17,585
TritonPoint Partners, LLC 0.04% 15,119 0% 0% $15,573
Scientech Research LLC 0.04% 15,105 0.01% $15,558
NORTHERN TRUST CORP 0.03% 12,530 0% 0% $12,906
Sound View Wealth Advisors Group, LLC 0.03% 10,000 0% 0% $10,300
SIMPLEX TRADING, LLC 0.01% 4,723 -63% 0% $4,864
Tower Research Capital LLC (TRC) 0.01% 4,104 +103% 0% $4,227

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
13
Latest
Q2 2026
Rows shown
1-13 of 13
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 8,322,155 $8,389,136 +$7,393,034 $1.03 31
2026 Q1 1,097,826 $592,510 -$18,462,721 $0.54 27
2025 Q4 3,655,018 $24,086,565 +$935,384 $6.59 30
2025 Q3 3,568,904 $10,948,007 -$154,104 $3.08 31
2025 Q2 3,726,254 $5,927,709 -$408,286 $1.60 30
2025 Q1 3,968,185 $7,492,715 -$1,152,368 $1.91 30
2024 Q4 4,262,920 $15,090,732 +$3,986,462 $3.54 28
2024 Q3 3,062,562 $13,557,086 +$372,349 $4.43 24
2024 Q2 2,974,014 $11,776,935 -$2,449,715 $3.96 20
2024 Q1 3,547,369 $14,756,693 +$12,607,257 $4.16 19
2023 Q4 516,778 $1,478,425 -$168,698 $2.86 10
2023 Q3 591,636 $1,561,335 -$597,671 $2.66 11
2023 Q2 678,595 $2,721,066 +$2,721,066 $4.01 12
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .